Skip to content
Screener

GeneDx Holdings WGS Deferred Tax Assets

Deferred Tax Assets at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$701K
NeoGenomics logo
NeoGenomicsNEO
$16.82M-15.8%
Azenta logo
AzentaAZTA
$15.84M+198%
Labcorp Holdings logo
Labcorp HoldingsLH
$24.4M+233%
Opko Health logo
Opko HealthOPK
$108.23M-4.5%

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$2.08B-31.7%
Enterprise value$2.08B-31.2%
P/S4.7×-3.7×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%
Net margin-17.6%
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.

The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001818331-26-000041
Line itemMarch 31, 2026 (Unaudited)December 31, 2025
Long-term debt, net of current portion96,73248,176
Long-term lease liabilities66,33156,046
Other liabilities711,641
Deferred taxes1,404757
Total liabilities252,177215,528
Purchase commitments and contingencies (Note 9)
Stockholders’ Equity:
Preferred Stock, $0.0001 par value: 1,000,000 shares authorized, 0 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is GeneDx Holdings's deferred tax assets?
GeneDx Holdings (WGS) reported deferred tax assets of $1.4M in Q1 2026.
How has GeneDx Holdings's deferred tax assets changed year-over-year?
GeneDx Holdings's deferred tax assets increased by 21.8% year-over-year, from $1.15M to $1.4M.
What is the long-term trend for GeneDx Holdings's deferred tax assets?
Over 5 years (2020 to 2025), GeneDx Holdings's deferred tax assets has grown at a 79.7% compound annual growth rate (CAGR), from $40.4K to $757K.
What does deferred tax assets mean?
Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.

Ask your AI about GeneDx Holdings's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude